ABRILADA
adalimumab-afzb · KIT · Pfizer Laboratories Div Pfizer Inc
Abrilada (adalimumab-afzb) is a prescription medication that belongs to a class of drugs called TNF inhibitors, used to treat various inflammatory conditions including rheumatoid arthritis, Crohn's disease, ulcerative colitis, and other autoimmune disorders. It comes as a kit for injection and works by reducing inflammation in the body.
Key Facts
- Brand Name
- ABRILADA
- Generic Name
- adalimumab-afzb
- NDC Code (Product)
0025-0333- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761118
- Marketing Start
- 12/14/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ABRILADA used for?
Abrilada (adalimumab-afzb) is a prescription medication that belongs to a class of drugs called TNF inhibitors, used to treat various inflammatory conditions including rheumatoid arthritis, Crohn's disease, ulcerative colitis, and other autoimmune disorders. It comes as a kit for injection and works by reducing inflammation in the body.
Is ABRILADA a controlled substance?
ABRILADA is not classified as a controlled substance by the DEA.
What is the generic name for ABRILADA?
The generic name for ABRILADA is adalimumab-afzb. There are no other listed brand versions of adalimumab-afzb.
What is the NDC code for ABRILADA ?
The NDC (National Drug Code) for ABRILADA is 0025-0333, listed by Pfizer Laboratories Div Pfizer Inc.
Other ABRILADA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)